Skip to main content
Clinical Trials/ITMCTR2100004233
ITMCTR2100004233
Not yet recruiting
Phase 1

A prospective cohort study of Chinese medicine intervention in overweight/obese patients with abnormal glucose tolerance (IGT)

The Affiliated Hospital of Changchun University of Chinese Medicine0 sitesTBD
ConditionsDiabetes

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Diabetes
Sponsor
The Affiliated Hospital of Changchun University of Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
The Affiliated Hospital of Changchun University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\) Aged 18 to 75 years;
  • 2\) Meet the diagnostic criteria of Western medicine for IGT;
  • 3\) Meet the diagnostic criteria of western medicine for overweight/obese or central obesity;
  • 4\) Informed consent has been signed.

Exclusion Criteria

  • 1\) Patients who have been diagnosed with type 1 diabetes, type 2 diabetes, gestational diabetes, secondary diabetes and other special types of diabetes;
  • 2\) People who have used hypoglycemic drugs continuously in recent 3 months;
  • 3\) Patients with severe other diseases or mental disorders;
  • 4\) Allergic to the known ingredients of the study drug and allergic constitution;
  • 5\) Pregnant or lactating women and those who have recently had family planning;
  • 6\) Patients with impaired liver and kidney function (ALT and AST are twice higher than the upper limit of normal value, and serum creatinine is abnormal).

Outcomes

Primary Outcomes

Not specified

Similar Trials